Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q4 2024 ▲▼ | Q1 2025 ▲▼ | Change ▲▼ | Q4 2024 ▲▼ | Q1 2025 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| BridgeBio Pharma, Inc.(BBIO) | 6,068,125 | 6,068,125 | 0 | $166.51M | $209.78M | 72.72% | +$43.27M |
| Verona Pharma plc (VRNA)ADS | 1,115,352 | 615,352 | -500,000 | $51.80M | $39.07M | 13.54% | -$12.73M |
| Syndax Pharmaceuticals, Inc.(SNDX) | 1,025,000 | 1,025,000 | 0 | $13.55M | $12.59M | 4.36% | -$963.5K |
| Bicara Therapeutics Inc. (BCAX) | 568,919 | 568,919 | 0 | $9.91M | $7.41M | 2.57% | -$2.50M |
| Monte Rosa Therapeutics, Inc.(GLUE) | 1,472,331 | 1,472,331 | 0 | $10.22M | $6.83M | 2.37% | -$3.39M |
| Nuvation Bio Inc.CL A(NUVB) | 2,541,009 | 2,541,009 | 0 | $6.76M | $4.47M | 1.55% | -$2.29M |
| COMPASS Pathways plcADS(CMPS) | 964,500 | 1,198,418 | +233,918 | $3.65M | $3.43M | 1.19% | -$218.3K |
| Biomea Fusion, Inc.(BMEA) | 798,757 | 798,757 | 0 | $3.10M | $1.70M | 0.59% | -$1.40M |
| CalciMedica, Inc.(CALC) | 521,114 | 521,114 | 0 | $1.84M | $995.3K | 0.35% | -$849.4K |
| Elevation Oncology Inc (ELEV) | 2,834,910 | 2,834,910 | 0 | $1.59M | $734.5K | 0.25% | -$853.0K |
| Aclaris Therapeutics, Inc.(ACRS) | 434,455 | 434,455 | 0 | $1.08M | $664.7K | 0.23% | -$412.7K |
| Marker Therapeutics, Inc.(MRKR) | 325,370 | 325,370 | 0 | $1.01M | $400.2K | 0.14% | -$611.7K |
| OnKure Therapeutics, Inc.CL A(OKUR) | 88,607 | 88,607 | 0 | $762.0K | $381.0K | 0.13% | -$381.0K |
| Poseida Therapeutics Inc. (PSTX) | 1,043,267 | 0 | -1,043,267 | $10.02M | $0 | — | -$10.02M |
| Viracta Therapeutics Inc (VIRX) | 288,571 | 0 | -288,571 | $46.2K | $0 | — | -$46.2K |